Literature DB >> 11280564

Hepatic manifestations of hemophagocytic syndrome: a study of 30 cases.

C de Kerguenec1, S Hillaire, V Molinié, C Gardin, C Degott, S Erlinger, D Valla.   

Abstract

OBJECTIVE: Hemophagocytic syndrome has been defined as the combination of a proliferation of cytologically benign, actively phagocytic macrophages in bone marrow, spleen, or lymph nodes in association with fever, cytopenia, splenomegaly, and hypertriglyceridemia. Hepatic dysfunction is often present but the nature of the hepatic lesions and related manifestations have not been fully characterized. The aim of this study was to ascertain the features of hepatic involvement in hemophagocytic syndrome.
METHODS: Thirty patients with hemophagocytic syndrome were retrospectively studied. Inclusion criteria included: 1) bone marrow with hemophagocytic histiocytosis, 2) clinical or biological signs of hepatic involvement, and 3) available liver specimen.
RESULTS: The association of fever, jaundice, and hepatomegaly or splenomegaly was present in 50% of the patients. Median value for serum alanine transaminase activity was five times the upper limit of normal values (range, 0.3-125), for serum alkaline phosphatase activity 2.7 upper limit of normal values (range, 0.2-47.7), for total bilirubin 136 micromol/L (range, 4-681 micromol/L), and for factor V 70% (range, 19-145%). Sinusoidal dilatation with hemophagocytic histiocytosis were found in the biopsy specimen in all patients. An underlying condition potentially responsible for altered immune function (lymphoma, leukemia, liver transplantation) was identified in 29 patients. Liver biopsy was diagnostic for the underlying condition in 15 patients (including eight cases with nonspecific bone marrow biopsy findings). High serum bilirubin, elevated serum alkaline phosphatase activity, low factor V level, and lack of treatment for the underlying disease were associated with a poor prognosis.
CONCLUSIONS: Hemophagocytic syndrome should be suspected in immunodeficient patients with fever, jaundice, and hepatosplenomegaly. Hepatic lesions are characterized by nonspecific sinusoidal dilatation with hemophagocytic histiocytosis and in 50% of the patients by alterations specific to the underlying condition. Liver biopsy is a useful diagnostic procedure in patients with this clinical presentation.

Entities:  

Mesh:

Year:  2001        PMID: 11280564     DOI: 10.1111/j.1572-0241.2001.03632.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  31 in total

1.  Haemophagocytic lymphohistiocytosis mimicking septic shock after the initiation of chemotherapy for squamous cell carcinoma of the neck.

Authors:  Madan Raj Aryal; Madan Badal; Smith Giri; Shambhu Aryal
Journal:  BMJ Case Rep       Date:  2013-06-27

2.  Haemophagocytic lymphohistiocytosis with pulmonary mucormycosis: fatal association.

Authors:  Deepanjan Bhattacharya; Rajalakshmi Iyer; Karthi Nallasamy; Kim Vaiphei
Journal:  BMJ Case Rep       Date:  2019-05-30

3.  An Unexpected Cause of Fever and Elevated Liver Enzymes.

Authors:  Diego Colom-Steele; Didi Mwengela; Elizabeth Harris; Dino Beduya
Journal:  Dig Dis Sci       Date:  2016-09       Impact factor: 3.199

4.  Hemophagocytic syndrome occurring in an adult liver transplant recipient having Still's disease.

Authors:  Sanjaya K Satapathy; M Isabel Fiel; Juan Del Rio Martin; Costica Aloman; Thomas D Schiano
Journal:  Hepatol Int       Date:  2010-10-24       Impact factor: 6.047

5.  Acute extrahepatic infectious or inflammatory diseases are a cause of transient mosaic pattern on CT and MR imaging related to sinusoidal dilatation of the liver.

Authors:  Maxime Ronot; Anne Kerbaol; Pierre-Emmanuel Rautou; Giuseppe Brancatelli; Pierre Bedossa; Dominique Cazals-Hatem; Dominique-Charles Valla; Valérie Vilgrain
Journal:  Eur Radiol       Date:  2015-11-28       Impact factor: 5.315

Review 6.  What nephrologists need to know about hemophagocytic syndrome.

Authors:  Alexandre Karras
Journal:  Nat Rev Nephrol       Date:  2009-06       Impact factor: 28.314

Review 7.  Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: Recommendations from the North American Consortium for Histiocytosis (NACHO).

Authors:  Michael B Jordan; Carl E Allen; Jay Greenberg; Michael Henry; Michelle L Hermiston; Ashish Kumar; Melissa Hines; Olive Eckstein; Stephan Ladisch; Kim E Nichols; Carlos Rodriguez-Galindo; Birte Wistinghausen; Kenneth L McClain
Journal:  Pediatr Blood Cancer       Date:  2019-07-24       Impact factor: 3.167

8.  Development of Mast Cell and Eosinophil Hyperplasia and HLH/MAS-Like Disease in NSG-SGM3 Mice Receiving Human CD34+ Hematopoietic Stem Cells or Patient-Derived Leukemia Xenografts.

Authors:  Laura J Janke; Denise M Imai; Heather Tillman; Rosalinda Doty; Mark J Hoenerhoff; Jiajie J Xu; Zachary T Freeman; Portia Allen; Natalie Wall Fowlkes; Ilaria Iacobucci; Kirsten Dickerson; Charles G Mullighan; Peter Vogel; Jerold E Rehg
Journal:  Vet Pathol       Date:  2020-11-19       Impact factor: 2.221

9.  Hepatic manifestations in hematological disorders.

Authors:  Jun Murakami; Yukihiro Shimizu
Journal:  Int J Hepatol       Date:  2013-03-31

Review 10.  Understanding organ dysfunction in hemophagocytic lymphohistiocytosis.

Authors:  Caroline Créput; Lionel Galicier; Sophie Buyse; Elie Azoulay
Journal:  Intensive Care Med       Date:  2008-04-22       Impact factor: 41.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.